134 related articles for article (PubMed ID: 2833607)
1. Production of antibodies of predetermined specificity against herpes simplex virus DNA polymerase and their use in characterization of the enzyme.
Thomas MS; Banks LM; Purifoy DJ; Powell KL
J Virol; 1988 May; 62(5):1550-7. PubMed ID: 2833607
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of purified herpes simplex virus DNA polymerase by two antipeptide sera.
Matthews JT; Stevens JT; Terry BJ; Cianci CW; Haffey ML
Virus Genes; 1990 Apr; 3(4):343-54. PubMed ID: 2161584
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus non-structural proteins. IV. Purification of the virus-induced deoxyribonuclease and characterization of the enzyme using monoclonal antibodies.
Banks L; Purifoy DJ; Hurst PF; Killington RA; Powell KL
J Gen Virol; 1983 Oct; 64 (Pt 10)():2249-60. PubMed ID: 6311954
[TBL] [Abstract][Full Text] [Related]
4. The herpes simplex virus DNA polymerase: analysis of the functional domains.
Knopf CW; Weisshart K
Biochim Biophys Acta; 1988 Dec; 951(2-3):298-314. PubMed ID: 2850009
[TBL] [Abstract][Full Text] [Related]
5. Comparison of DNA polymerase activities induced by herpes simplex virus types 1 and 2.
Purifoy DJ
Intervirology; 1975-1976; 6(6):356-66. PubMed ID: 187552
[TBL] [Abstract][Full Text] [Related]
6. DNA-binding protein associated with herpes simplex virus DNA polymerase.
Vaughan PJ; Purifoy DJ; Powell KL
J Virol; 1985 Feb; 53(2):501-8. PubMed ID: 2578573
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of herpes simplex virus type 1 DNA polymerase activity by peptides from the UL42 accessory protein is largely nonspecific.
Owsianka AM; Hart G; Murphy M; Gottlieb J; Boehme R; Challberg M; Marsden HS
J Virol; 1993 Jan; 67(1):258-64. PubMed ID: 8380075
[TBL] [Abstract][Full Text] [Related]
8. Interactions between herpes simplex virus DNA-binding proteins.
Vaughan PJ; Banks LM; Purifoy DJ; Powell KL
J Gen Virol; 1984 Nov; 65 ( Pt 11)():2033-41. PubMed ID: 6094715
[TBL] [Abstract][Full Text] [Related]
9. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies specific for the alpha subunit of the Escherichia coli DNA polymerase III holoenzyme.
Wu YH; Franden MA; Hawker JR; McHenry CS
J Biol Chem; 1984 Oct; 259(19):12117-22. PubMed ID: 6090455
[TBL] [Abstract][Full Text] [Related]
11. Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries.
Sanna PP; Williamson RA; De Logu A; Bloom FE; Burton DR
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6439-43. PubMed ID: 7604009
[TBL] [Abstract][Full Text] [Related]
12. Studies on the herpes simplex virus alkaline nuclease: detection of type-common and type-specific epitopes on the enzyme.
Banks LM; Halliburton IW; Purifoy DJ; Killington RA; Powell KL
J Gen Virol; 1985 Jan; 66 ( Pt 1)():1-14. PubMed ID: 2578550
[TBL] [Abstract][Full Text] [Related]
13. Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus.
Strynadka NC; Redmond MJ; Parker JM; Scraba DG; Hodges RS
J Virol; 1988 Sep; 62(9):3474-83. PubMed ID: 2457115
[TBL] [Abstract][Full Text] [Related]
14. Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodies.
Welling-Wester S; Feijlbrief M; Koedijk DG; Drijfhout JW; Weijer WJ; Scheffer AJ; Welling GW
Arch Virol; 1994; 138(3-4):331-40. PubMed ID: 7527999
[TBL] [Abstract][Full Text] [Related]
15. Application of antibody to synthetic peptides for characterization of the intact and truncated alpha 22 protein specified by herpes simplex virus 1 and the R325 alpha 22- deletion mutant.
Ackermann M; Sarmiento M; Roizman B
J Virol; 1985 Oct; 56(1):207-15. PubMed ID: 2993651
[TBL] [Abstract][Full Text] [Related]
16. Translational regulation of herpes simplex virus DNA polymerase.
Yager DR; Marcy AI; Coen DM
J Virol; 1990 May; 64(5):2217-25. PubMed ID: 1691312
[TBL] [Abstract][Full Text] [Related]
17. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
19. Crossed immunoelectrophoretic analysis and viral neutralizing activity of five monospecific antisera against five different herpes simplex virus glycoproteins.
Vestergaard BF; Norrild B
IARC Sci Publ (1971); 1978; (24 Pt 1):225-34. PubMed ID: 221329
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of an anti-idiotypic antibody specific for a monoclonal antibody to glycoprotein D of herpes simplex virus.
Lathey JL; Rouse BT; Wiley DE; Courtney RJ
Immunology; 1986 Jan; 57(1):29-35. PubMed ID: 3002969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
